NCT01467713 Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder Status TERMINATED Phase PHASE3
NCT01467700 Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder Status TERMINATED Phase PHASE3
NCT01466829 Treatment With PTH After Sternotomy in Cardiac Surgery Patients Status COMPLETED Phase PHASE3
NCT01459367 Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis Status COMPLETED Phase PHASE3
NCT01458301 Efficacy and Safety of TAK-385 in the Treatment of Endometriosis Status COMPLETED Phase PHASE2
NCT01456260 Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) Status COMPLETED Phase PHASE3
NCT01456247 Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin Status COMPLETED Phase PHASE3
NCT01456195 Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01456169 A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone Status COMPLETED Phase PHASE3
NCT01456130 Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01456117 Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants Status COMPLETED Phase PHASE1
NCT01454973 Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects Status COMPLETED Phase N/A
NCT01452776 Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis Status COMPLETED Phase PHASE3
NCT01452763 Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin Status COMPLETED Phase PHASE3
NCT01452750 Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) Status COMPLETED Phase PHASE3
NCT01452724 Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer Status COMPLETED Phase PHASE3
NCT01452711 Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer Status COMPLETED Phase PHASE3
NCT01452698 Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis Status COMPLETED Phase PHASE3
NCT01452685 A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis Status COMPLETED Phase PHASE2
NCT01452659 Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids Status COMPLETED Phase PHASE2